Cargando…
Primary effusion lymphoma in an elderly patient effectively treated by lenalidomide: case report and review of literature
Primary effusion lymphoma (PEL) is a rare aggressive subset of non-Hodgkin B-cell lymphoma. It is caused by Kaposi sarcoma-associated herpesvirus/human herpesvirus type 8 (KSHV/HHV8). It occurs mainly, but not exclusively, in HIV-positive patients. PEL predominantly develops in serous cavities and o...
Autores principales: | Antar, A, El Hajj, H, Jabbour, M, Khalifeh, I, EL-Merhi, F, Mahfouz, R, Bazarbachi, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972705/ https://www.ncbi.nlm.nih.gov/pubmed/24608734 http://dx.doi.org/10.1038/bcj.2014.6 |
Ejemplares similares
-
Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma
por: Moodad, Sara, et al.
Publicado: (2020) -
Combination of Arsenic and Interferon-α Inhibits Expression of KSHV Latent Transcripts and Synergistically Improves Survival of Mice with Primary Effusion Lymphomas
por: El Hajj, Hiba, et al.
Publicado: (2013) -
HHV8‐unrelated primary effusion lymphoma in a patient with HBV‐related liver cirrhosis: A case successfully treated with rituximab and lenalidomide
por: Liao, Peng‐Jun, et al.
Publicado: (2023) -
Primary Effusion Lymphoma-like Lymphoma Mimicking Tuberculous Pleural Effusion: Three Case Reports and a Literature Review
por: Hayashino, Kenta, et al.
Publicado: (2022) -
A Rare Case Report of Photosensitivity in Non-Hodgkin’S Lymphoma Treated with Lenalidomide
por: Soni, Rajesh K, et al.
Publicado: (2020)